Cargando…
Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104725/ https://www.ncbi.nlm.nih.gov/pubmed/30594446 http://dx.doi.org/10.1016/j.clml.2018.11.020 |
_version_ | 1783512292851187712 |
---|---|
author | Bond, David A. Dotson, Emily Awan, Farrukh T. Baiocchi, Robert A. Blum, Kristie A. Maddocks, Kami |
author_facet | Bond, David A. Dotson, Emily Awan, Farrukh T. Baiocchi, Robert A. Blum, Kristie A. Maddocks, Kami |
author_sort | Bond, David A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7104725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71047252020-03-31 Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma Bond, David A. Dotson, Emily Awan, Farrukh T. Baiocchi, Robert A. Blum, Kristie A. Maddocks, Kami Clin Lymphoma Myeloma Leuk Article Elsevier Inc. 2019-03 2018-11-29 /pmc/articles/PMC7104725/ /pubmed/30594446 http://dx.doi.org/10.1016/j.clml.2018.11.020 Text en © 2018 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bond, David A. Dotson, Emily Awan, Farrukh T. Baiocchi, Robert A. Blum, Kristie A. Maddocks, Kami Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma |
title | Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma |
title_full | Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma |
title_fullStr | Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma |
title_full_unstemmed | Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma |
title_short | Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma |
title_sort | febrile hypotensive reactions following abvd chemotherapy in patients with ebv-associated classical hodgkin lymphoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104725/ https://www.ncbi.nlm.nih.gov/pubmed/30594446 http://dx.doi.org/10.1016/j.clml.2018.11.020 |
work_keys_str_mv | AT bonddavida febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma AT dotsonemily febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma AT awanfarrukht febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma AT baiocchiroberta febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma AT blumkristiea febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma AT maddockskami febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma |